Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
Status:
Unknown status
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate tolerability, acceptability and potential efficacy
of 4 months of maintenance treatment with Mirtazapine as compared to placebo for patients
with co-occurring amphetamine-type stimulant and opioid dependence (COATS) receiving
buprenorphine maintenance treatment (BMT) in Kota Bharu.
Phase:
Phase 3
Details
Lead Sponsor:
Universiti Sains Malaysia University of Science Malaysia